Device therapy for remodeling in congestive heart failure

Current Heart Failure Reports

Volumn 4, Issue 1, 2007, Pages 53-58

  Carraway, Edward A ^a   Rayburn, Barry K ^a  

^a THT 321M ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MARLEX;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR EQUIPMENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEVICE THERAPY; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; MEDICAL INSTRUMENTATION; MITRAL VALVE REGURGITATION; NONHUMAN; REVIEW;

ANIMALS; CARDIAC PACING, ARTIFICIAL; CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 34247528435     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-007-0027-0     Document Type: Review

References (35)

1. Francis GS: Pathophysiology of chronic heart failure. Am J Med 2001, 110:37S-46S.
2. Sabbah HN, Kono T, Stein PD, et al.: Left ventricular shape changes during the course of evolving heart failure. Am J Physiol 1992, 263:H266-270.
3. Frigerio M, Roubina E: Drugs for left ventricular remodeling in heart failure. Am J Cardiol 2005, 96:10L-18L.
4. Reddy HK, Tjahja IE, Campbell SE, et al.: Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation. Mol Cell Biochem 2004, 264:183-191.
5. Kass DA, Baughman KL, Pak PH, et al.: Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist. Circulation 1995, 91:2314-2318.
6. Cohn JN, Ferrari R, Sharpe N: Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000, 35:569-582.
7. Cohn JN: Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation 1995, 91:2504-2507.
8. Inoue M, McCarthy PM, Popovic ZB, et al.: The Coapsys device to treat functional mitral regurgitation: in vivo long-term canine study. J Thorac Cardiovasc Surg 2004, 127:1068-1076.
9. • Acker MA, Bolling S, Shemin R, et al.: Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 2006, 132:568-577. This study involved 193 patients randomized to either mitral valve surgery alone or mitral valve surgery plus Acorn Corcap cardiac suport device, making it the largest published trial to date of a passive constraint device. Results showed showed that in patients undergoing mitral valve surgery, addition of the Acorn CorCap clearly provides additional benefits including reverse remodeling and improvement in quality of life.
10. Donal E, Leclercq C, Linde C, Daubert JC: Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J 2006, 27:1018-1025.
11. Murphy RT, Sigurdsson G, Mulamalla S, et al.: Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol 2006, 97:1615-1621.
12. Walsh RG: Design and features of the Acorn CorCap cardiac support device: the concept of passive mechanical diastolic support. Heart Fail Rev 2005, 10:101-107.
13. Sabbah HN: The cardiac support device and the Myosplint: treating heart failure by targeting left ventricular size and shape. Ann Thorac Surg 2003, 75:S13-19.
14. Magovern JA: Experimental and clinical studies with the Paracor cardiac restraint device. Semin Thorac Cardiovasc Surg 2005, 17:364-368.
15. Chaudhry PA, Mishima T, Sharov VG, et al.: Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thorac Surg 2000, 70:1275-1280.
16. Sabbah HN: Global left ventricular remodeling with the Acorn cardiac support device: hemodynamic and angiographic findings in dogs with heart failure. Heart Fail Rev 2005, 10:109-115.
17. Raman JS, Byrne MJ, Power JM, Alferness CA: Ventricular constraint in severe heart failure halts decline in cardio vascular function associated with experimental dilated cardiomyopathy. Ann Thorac Surg 2003, 76:141-147.
18. Pilla JJ, Blom AS, Brockman DJ, et al.: Ventricular constraint using the acorn cardiac support device reduces myocardial akinetic area in an ovine model of acute infarction. Circulation 2002, 106:I207-211.
19. Blom AS, Mukherjee R, Pilla JJ, et al.: Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation 2005, 112:1274-1283.
20. Cheng A, Nguyen TC, Malinowski M, et al.: Passive ventricular constraint prevents transmural shear strain progression in left ventricle remodeling. Circulation 2006, 114:I79-86.
21. Raman JS, Hata M, Storer M, et al.: The mid-term results of ventricular containment (Acorn wrap) for end-stage ischemic cardiomyopathy. Ann Thorac Cardiovasc Surg 2001, 7:278-281.
22. Starling RC, Jessup M: Worldwide clinical experience with the CorCap cardiac support device. J Card Fail 2004, 10:S225-233.
23. Lembcke A, Dushe S, Dohmen PM, et al.: Early and late effects of passive epicardial constraint on left ventricular geometry: ellipsoidal re-shaping confirmed by electron- beam computed tomography. J Heart Lung Transplant 2006, 25:90-98.
24. Mann DL, Acker MA, Jessup M, et al.: Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York heart association class III-IV heart failure. J Card Fail 2004, 10:185-192.
25. Shelton RJ, Velavan P, Nikitin NP, et al.: Clinical trials update from the American Heart Association meeting: ACORN-CORCAP, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study. Eur J Heart Fail 2005, 7:127-135.
26. Rayburn BK, Aranda JM, Boehmer JP, et al.: The Paracor ventricular support system: initial US experience [abstract]. Circulation 2006, 114:II-710.
27. Aranda JM, Klodell CT, Rayburn BK, et al.: Early worldwide experience with the Paracor HeartNet™ elastic restraint device [abstract]. J Card Failure 2006, 12:S46.
28. Biderman RWW, Grothues R, Klein H, et al.: Improvement in mechanical dyssynchrony in patients with dilated cardiomyopathy: impact of LV mesh [abstract]. J Card Failure 2006, 12:S45.
29. Hamner C, Ruth G, Raffe M, et al.: Safety and biocompatibility of the Myosplint system - a passive implantable device that alters ventricular geometry for the treatment of heart failure. ASAIO J 2004, 50:438-443.
30. Fukamachi K, McCarthy PM: Initial safety and feasibility clinical trial of the Myosplint device. J Card Surg 2005, 20:S43-47.
31. Liel-Cohen N, Guerrero JL, Otsuji Y, et al.: Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation: insights from 3-dimensional echocardiography. Circulation 2000, 101:2756-2763.
32. Fukamachi K, Popovic ZB, Inoue M, et al.: Changes in mitral annular and left ventricular dimensions and left ventricular pressure-volume relations after off-pump treatment of mitral regurgitation with the Coapsys device. Eur J Cardiothorac Surg 2004, 25:352-357.
33. Fukamachi K, Inoue M, Popovic ZB, et al.: Off-pump mitral valve repair using the Coapsys device: a pilot study in a pacing-induced mitral regurgitation model. Ann Thorac Surg 2004, 77:688-692.
34. Mishra YK, Mittal S, Jaguri P, Trehan N: Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. Ann Thorac Surg 2006, 81:42-46.
35. Grossi EA, Saunders PC, Woo YJ, et al.: Intraoperative effects of the coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Ann Thorac Surg 2005, 80:1706-1711.